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ABSTRACT
Despite the controversy regarding the existence and 
physiological relevance of class A G protein-coupled 
receptor dimerization, there is substantial evidence 
for functional interactions between the dopamine 
D2 receptor (D2R) and the adenosine A2A receptor 
(A2AR). A2AR-D2R complexes have been detected 
in rodent brains by proximity ligation assay; however, 
their existence in the human brain has not been 
demonstrated. In this study, we used Brightfield 
proximity ligation assay, combined with a systematic 
sampling and a parameter-free naive Bayesian 
classifier, and demonstrated proximity between 
the D2R and the A2AR in the adult human ventral 
striatum, consistent with their colocalization within 
complexes and the possible existence of D2R-A2AR 
heteromers. These methods are applicable to the 
relative quantification of proximity of two proteins, 
as well as the expression levels of individual proteins.
METHOD SUMMARY
Brightfield proximity ligation assay was used 
to assess the expression of G protein-coupled 
receptors and their proximity in postmortem adult 
human brains. A novel automated machine learning 
method (Bayesian optimized PLA signal sorting) 
was developed to automatically quantify Brightfield 
proximity ligation assay data.
The dopamine receptor type 2 (D2R) is an extensively studied class A G protein-
coupled receptor (GPCR) that has been shown to play a critical role in various 
brain functions and has been implicated in a variety of neuropsychiatric 
disorders, including schizophrenia [1,2], Parkinson’s [3,4], Alzheimer’s [5] and 
Huntington’s disease [7] as well as addiction [8]. In addition, the D2R is the 
common target of all current antipsychotic medications [9], which has led to 
extensive publication of literature regarding its pharmacological and signaling 
properties [10]. Previous studies in cell lines suggest that D2Rs may function 
as a part of heteromeric complexes, in which D2R activity and signaling can 
be modulated by another receptor subunit [11–14]. The putative heteromer 
formed by the D2R with the adenosine A2A receptor (A2AR) is one of the most 
studied among the class A GPCRs [15–19], and it has been hypothesized that 
pharmacological targeting of A2AR could be an efficient strategy to modulate 
D2R activity [20,21]. However, the structural properties of class A receptor 
heteromers, their existence in vivo and their relevance to receptor physiology 
or pathophysiology remain unclear and a topic of active study and 
debate [22–24]. The signaling properties of putative D2R-A2AR heteromers 
have been mostly studied in heterologous systems, and it is important to study 
these complexes in native mammalian brain.
Both time-resolved fluorescence resonance energy transfer-based 
assays [25,26] and antibody-based in situ proximity ligation assays 
(PLAs) [27,28] have been used to study receptor complexes in native tissue. 
Using fluorescent PLA, we and others have successfully detected endogenous 
D2R-A2AR complexes in the rodent striatum, which provided ex vivo evidence 
for the existence of D2R-A2AR heteromeric complexes composed of native 
receptors [28,29]. However, the existence of D2R-A2AR complexes in human 
brains has yet to be established.
PLA has been widely used to assess protein–protein interaction, protein 
expression and post-translational modification both in vitro and ex vivo [30–33]. 
PLA puncta are generated when a pair of oligonucleotide-conjugated antibodies 
bind to neighboring antigens, followed by ligation of the oligonucleotides and 
subsequent rolling cycle amplification, leading to DNA structure that can be 
detected by fluorophore- or horseradish peroxidase-labeled oligonucleotide 
probes. In contrast to standard immunohistochemistry and immunofluores-
cence, both of which rely on a field of precipitate or fluorescence that can 
only be quantified by total intensity, PLA results in individual puncta, allowing 
relative quantification of proteins (single PLA) or complexes (dual PLA) with 
higher spatial resolution. To date, PLA has been applied to postmortem human 
brain in a limited number of studies. PLA was used to assess α-synuclein 
oligomers in Parkinson’s disease [34] and to detect the interaction between 
SORL1 and APP in Alzheimer’s disease [35]. A limiting factor in applying 
these approaches to the human brain relates to the size of the samples, 
which make it challenging to obtain representative data while minimizing 
the number of samples, as classical stereology techniques are extremely 
time consuming. Further, PLA is highly sensitive to tissue processing [28], and 
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its use in postmortem human brain tissue 
requires additional consideration and optimi-
zation. Notably, human brains are classically 
fixed by immersion in fixative and paraffin-
embedded, a method that is not typically 
used with rodent brain tissue.
Here, we optimized in situ PLA to detect 
D2R, A2AR and D2R-A2AR complexes with 
Brightfield microscopy in the human ventral 
striatum and developed a new approach, 
combining whole-slide scanning, systematic 
random sampling and parameter-free 
automated image analysis that employs 
a naive Bayesian classifier for faithful and 
robust signal separation. This study consti-
tutes a proof-of-concept for relative quanti-
fication of individual proteins and antigen 




Information about human brain specimens 
is described in Supplementary Table 1, and 
tissue processing is described in the Supple-
mentary data. Anti-D2R (rabbit polyclonal, 
ABN462, MilliporeSigma, MO, USA) was used 
at a final concentration of 1.67 μg/ml for 
single PLA (recognition of one antigen), and 
5 μg/ml for dual PLA (proximity between two 
antigens). Anti-A2AR (mouse monoclonal, 
05-717, MilliporeSigma) was used at 1 μg/ml 
for single PLA and at 1.67 μg/ml for dual PLA. 
The specificity of anti-D2R and anti-A2AR 
antibodies was previously validated using 
brain tissue from D2R and A2AR knockout 
mice [28,36]. PLA was performed with anti-
rabbit and anti-mouse secondary antibody-
conjugated PLA probes and the Brightfield 
detection kit (MilliporeSigma Duolink®, MO, 
USA) according to the user’s manual (Supple-
mentary data). A detailed protocol is 
available online.
Microscopy & sampling
For fluorescent staining, images were taken 
with a Zeiss LSC510 confocal laser-scanning 
microscope (Zeiss, Germany) using a 63× 
oil objective and z-stack scanning with a 
step interval of 0.5 μm. Brightfield whole-
slide images were taken with a Leica SCN400 
(Leica Biosystems, IL, USA) at the Herbert 
Irving Comprehensive Cancer Center 
(HICCC), using tube lens magnification (2×) 
in addition to a 20× objective lens (Numerical 
Aperture 0.65) to achieve 40× magnification 
and z-stack scanning with a step interval of 
1 μm. Whole-slide scanned virtual images 
were viewed with a Leica SCN400 image 
viewer (version 2.2), and a single layer with 
the most PLA puncta in focus was used to 
export images (zoom at 40×) for PLA signal 
quantification.
A systematic random sampling method 
adapted from Gundersen et al. [37] was 
performed to choose areas in the brain 
region of interest (ROI) to quantify the PLA 
signal (Supplementary Figure 1).
Quantification with the Bayesian 
optimized PLA signal sorting package
We designed a custom MATLAB package 
Bayesian optimized PLA signal sorting 
(BOPSS) to analyze PLA signal images [38]. 
To use the program, we input a folder 
containing Brightfield images for single and 
dual PLA samples and negative controls. In 
the first step of BOPSS, clusters of noncel-
lular foreground pixels (putative puncta [PP]) 
are located in all of the images using an 
approach typically used in the processing 
of histological samples [39]. The PP are then 
randomly split into two groups (training set 
and test set). The test set of PP is used to 
calculate two distributions (negative control 
distribution and PLA signal distribution) for 
each of the 11 intensity-based and morpho-
logical features (11 pairs of distributions in 
total are generated). Next, these 11 pairs of 
distributions are used to categorize PP in 
the test set. At this step, for each feature, 
each punctum is determined to be more 
similar to the trained PLA signal distribution 
or the trained noise distribution. Some 
puncta may be more similar to the PLA signal 
in a few features, but more similar to the 
noise in the rest of the features. To account 
for all 11 features, a product (the likelihood) 
of the punctum being PLA signal is calcu-
lated and compared with the likelihood of it 
being noise. If the likelihood of the punctum 
being a PLA signal is higher than the 
likelihood of the punctum being noise, it is 
preserved as a PLA signal.
RESULTS & DISCUSSION
Optimized PLA assay for rodent & 
human brain sections
Whereas PLA on rodent brain fixed by trans-
cardial perfusion has been widely 
validated [28,33], human brain tissue is 
classically fixed by direct immersion in 
formalin and paraffin-embedding, which 
could alter the detection and quality of the 
signal. Tissue preparation, especially 
fixation, is known to alter morphology and 
immunostaining results [40–42]. To assess 
how alternative fixation approaches may 
affect PLA imaging results in human brain 
sections, we compared the results of 
immunofluorescent PLA (PLA-FL) on mouse 
brain sections following different fixation 
approaches. We performed single-recog-
nition PLA (single PLA), which allows 
detection of an antigen with only one primary 
antibody, for D2R on sections of mouse 
brains that underwent two different fixation 
protocols: 1 fixation in 4% PFA overnight 
after perfusion (perfusion fixation), or 2 
fixation by direct immersion in 4% PFA for 
4 days without perfusion (direct immersion 
fixation). With both fixation protocols, we 
obtained a clear PLA signal (puncta) of D2R 
distributed throughout the striatum, with one 
major difference in the nonspecific 
background. As described previ -
ously [28,33,36] we observed a fluorescent 
signal in the nuclear compartments in 
samples fixed through perfusion (Figure 1A 
& C), whereas this background was much 
lower in sections from brains fixed without 
perfusion (Figure 1B & D). These results 
suggested that the PLA signal for D2Rs from 
tissue fixed using the direct immersion 
method is preserved, whereas the nuclear 
background is greatly reduced. Although the 
exact cause of this nuclear background is 
unclear, it was previously described with 
PLA-FL from perfused adult animals [28,43] 
and on brain slices from mouse pups (P0-P1) 
fixed by direct immersion in fixative [33]. In 
addition, we performed PLA-FL on sections 
from snap-frozen mouse brains, which were 
fixed with 4% PFA after cryosectioning, and 
observed a similar strong nuclear 
background (data not shown). It is therefore 
tempting to propose that it is the rapid 
fixation process, which occurs through intra-
cardial perfusion of fixative, or rapid 
penetration of the fixative in the much 
smaller pup brain or a thin cryosection, 
which is responsible for the nuclear 
background. This signal does not result from 
specific or nonspecific binding of primary or 
secondary antibodies, since it is not 
detectable in regular immunostaining with 
anti-D2R or anti-A2AR antibodies. Moreover, 
the nuclear background is still present 
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when antibodies are omitted in the PLA 
process [28]. We speculate that the cross-
linking of chromatin by rapid fixation could 
result in nonspecific binding of the labeled 
oligonucleotides used during the detection 
step of the PLA. Regardless of the underlying 
causes, our results help to explain the 
dramatic differences in background 
described in previously published 
studies [28,43,44]. 
Next, we performed PLA-FL on paraffin-
embedded human brain sections. In 
marked contrast to mouse brain sections, a 
prominent nonspecific signal was observed, 
detectable with either 488 or 564-nm 
excitation (data not shown) in the form 
of dense aggregates that often accumu-
lated in the soma (Figure 2A-B), suggesting 
a nonspecific autofluorescence signal, 
in addition to detection of specific PLA 
puncta. To address this issue, we replaced 
the original PLA-FL with a Brightfield-
compatible detection method, Brightfield 
PLA (PLA-BF), which allows visualization of 
the PLA signal with a chromogenic substrate 
of horseradish peroxidase. The PLA-BF for 
single-recognition of the A2AR showed a 
similar PLA punctate pattern, however, 
without the nonspecific signal observed with 
the PLA-FL method (Figure 2C & D). 
Autofluorescence is a common issue 
for imaging the adult human brain but not 
with transmitted light. Therefore, PLA-BF 
avoids the autofluorescence that confounds 
PLA-FL (Figure 2) and even standard 
immunofluorescence in brain samples 
from human adults and aged animals [45]. 
Notably, PLA-BF and PLA-FL on mouse brain 
sections yielded comparable results (data 
not shown). Altogether, these observations 
suggest that PLA-BF is a superior alternative 
to PLA-FL for paraffin sections from human 
autopsy brains. Moreover, the stability 
of the Brightfield-based signal compared 
with fluorescence-based methods allows a 
better conservation of the samples without 
the photobleaching inherent to the imaging 
of fluorescent samples.
Assessing the expression of D2R, A2AR 
& D2R-A2AR in the human brain
To assess the expression of D2R, A2AR and 
D2R-A2AR complexes, we performed single 
PLA-BF for each individual receptor, and dual 
PLA-BF for D2R-A2AR complexes on coronal 
sections of adult human ventral striatum 
that included the nucleus accumbens 
(NAcc) and limited parts of the putamen 
(Ptm) and caudate (Cdt). The anatomical 
structure was confirmed by Luxol fast blue 
and cresyl violet (LFB/CV) staining, which 
stains myelin and Nissl substance, respec-
tively (Supplementary Figure 1A–C). Consid-
ering the low number of PLA puncta for 
D2R-A2AR complexes relative to individual 
D2R and A2AR in mouse brains [28], we used 
different concentrations of primary 
antibodies for dual and single PLAs to obtain 
optimal staining results, avoiding saturation 
in single PLA that can lead to overcrowded 
signal instead of countable puncta. In all 
tested samples, we observed strong signal 
for single PLA of D2R and A2AR and a clear 
but weaker signal for dual PLA of D2R-A2AR 
complexes in the NAcc (Figure 3 A–I), Ptm 
and Cdt (data not shown). The dual PLA for 
negative controls that omitted anti-A2AR 
antibody showed no or very few detectable 
puncta in the same areas (Figure 3 J–L and 
data not shown). These results support the 
existence of D2R-A2AR complexes in native 
human brains. We note that interpretation 
of the puncta from single PLA is complex 
with our current reagents, since the 
polyclonal secondary antibodies can bind 
to either two epitopes on a single primary 
antibody bound to a single antigen, or to two 
different primaries bound to proximal 
antigens. We expect that the former will be 
more efficient. In addition, we had to use 
different primary antibody concentrations 
for single and dual PLA so as to not saturate 
the single PLA signal. For these reasons, the 
absolute number of single PLA and dual PLA 
puncta cannot be compared directly but 
must be used for relative quantitation. 
Systematic random sampling & 
automated quantification of the PLA-BF 
signal in human brain sections
Because the PLA signal appears as puncta, 
quantitative analysis of proteins is more 
plausible than in traditional immunostaining. 
However, the large size of the human brain 
sections makes it challenging to quantify 
the PLA signal from an entire brain region. 
For example, the brain ROI in this study, the 
NAcc, was approximately 40 mm2 (Supple-
Perfusion Direct immersion
Figure 1. The effect of fixation on the nonspecific nuclear signal in single-recognition PLA-FL 
in mouse brain tissue. Representative images of D2R single-recognition PLA in coronal striatal 
section from mouse brains fixed by transcardial perfusion of fixative (A & C) or by direct immersion 
in fixative (B & D). DAPI counterstaining (blue) (C & D) labels nuclei. Note that in the nuclear area, the 
hazy background signal is almost absent and the puncta overlapping the nuclei are much reduced 
in the non-perfused tissue compared with the perfused tissue. Scale bar, 50 μm.
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mentary Table 2). Therefore, as described in 
the Supplementary data, we obtained virtual 
images by whole-slide scanning, divided the 
ROI into a series of sampling areas and only 
quantified the PLA signal in the areas (named 
counting loci in this study) that were selected 
by a systematic random sampling method 
adapted from Gundersen et al. [37] (Supple-
mentary Figure 1F). Therefore, the total 
analyzed area represented only ∼3% of the 
ROI (Supplementary Table 2) but was 
composed of a set of representative counting 
loci evenly distributed within the entire ROI.
To efficiently and reproducibly quantify 
PLA puncta across our large dataset in an 
unbiased way, we applied and compared 
three different quantification approaches. 
Two of these approaches, Analyze Particles 
(ImageJ) [46] and Spot detector (ICY) [47], 
rely on the user to set intensity and size 
parameters to distinguish clusters of pixels 
against the background of an image. In 
contrast, our custom MATLAB package 
BOPSS, which we designed to automatically 
quantify PLA-BF signal, is an unsupervised 
machine-learning approach and requires no 
parameters to be set by the user.
Analyze particles (Image J) depends on 
threshold and particle size to detect PLA 
puncta. The automated threshold (Figure 4: 
ImageJ_auto) worked well for the dual PLA 
signal, but underestimated the signal for 
single PLA, and showed high counts in 
the negative controls (Figure 4D–F, P-Q), 
which resulted in a low signal (the dual PLA 
signal)/background noise (the negative 
control signal) (S/N = 2.14). Most of the 
nonspecific puncta in the negative controls 
detected by Analyze Particles corresponded 
to background in the nuclear area, typical 
of the signal obtained with classical DNA 
intercalating reagents like DAPI or Hoechst. 
Manually optimizing the threshold reduced 
the nonspecific detection in the negative 
controls but caused severe undercounting 
for both dual and single PLA and failed to 
improve S/N (data not shown). Adjusting 
the size of particles also failed to improve 
S/N or undercounting of specific PLA signal 
(data not shown). These results suggested 
that Analyze Particles (Image J) cannot 
properly discriminate specific and nonspe-
cific signals and underestimated specific 
PLA signal. 
Spot detector (ICY) detects PLA puncta 
through a series of functions: 1, Scales 
that determine the sensitivity and the size 
of spots to detect, and 2, a Filtering that 
determines the maximum and minimum 
size of accepted objects. When parameters 
were optimized for dual PLA, this method 
showed very little – if any – nonspe-
cific detection in the negative controls 
and good detection for dual PLA, but 
noticeable underestimation for single PLA 
(Figure 4G–I & P-Q: ICY_D). With optimized 
parameters for single PLA, Spot Detector 
showed increased detection in every PLA 
assay, including nonspecific detection in 
the negative controls (Figure 4J–L & P–Q: 
ICY_S). Therefore, two different sets of 
parameters were necessary for specific and 
efficient detection for single PLA (puncta of 
high density) and dual/negative PLA signal 
(puncta of low density).
In contrast to ImageJ and ICY, BOPSS 
uses a machine-learning algorithm to learn 
the properties of the puncta based on the 
data. It measures a variety of features for 
each cluster of pixels and uses the distri-
butions of these features to contrast 
between negative controls and samples. 
It processes color images containing cells 
and PLA signal without relying on any user-
defined parameters, but rather on the speci-
fication of negative control and experimental 
images. On a standard laptop PC (2.6 GHz 
CPU), we analyzed the output results for 
10 megabytes of images in 5 s. In a pretest 
with three full counting images of each PLA 
condition, single PLA, dual PLA and negative 
control, this all-in-one script completed 
machine learning-based optimization and 
quantification automatically. Compared with 
the pre-optimization counting (BOPSS_0) 
that only selected puncta based on size and 
color, the optimized quantification BOPSS 











Figure 2. Differences between PLA-FL and PLA-BF detection methods. Representative images 
of negative controls (A & C) and A2AR single-recognition PLA-FL (B), PLA-BF (D) performed on 
paraffin-embedded human brain sections of the ventral striatum from the same human subject. 
The arrows in B and D indicate representative PLA puncta. Hematoxylin counterstaining (blue) 
labels nuclei (C & D). Scale bar, 20 μm. Note the high autofluorescence background in PLA-FL and 
the clean background in the PLA-BF.
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Figure 3. Detection of single PLA for A2AR and D2R, and dual PLA for D2R-A2AR by PLA-BF in the 
NAcc. The expression of A2AR (A–C), D2R (D–F), D2R-A2AR (G–I) and negative controls (J–L) in 
the NAcc was detected in three human subjects, PI12260, PI12270 and PI12277. Scale bar: 25 μm.
background noise (the negative control 
signal) ratio for dual PLA from 1.63 to 8.41, 
reduced the averaged counts in the negative 
controls from 1165 ± 300 to 96 ± 29 (puncta/
mm2), a 92% reduction in false positives, 
while maintaining efficient detection in 
both dual and single PLA (Figure 4 & data 
not shown).
To assess the accuracy of BOPSS, we 
randomly selected three areas (Supple-
mentary Figure 2A–C) covering 43% of a 
full counting image and quantified the PLA 
puncta using manual counting (Supple-
mentary Figure 2J–L) or with BOPSS 
(BOPSS_0 and BOPSS, Supplementary 
Figure 2D–I). The results showed that 
BOPSS achieved remarkably similar results 
for dual PLA and negative control compared 
with the manual counting (Supplementary 
Figure 2N). For single PLA, BOPSS counted 
slightly more PLA puncta than the mean of 
four independent manual counting attempts 
(Supplementary Figure 2M). However, 
manual counting, although highly repro-
ducible for the low-density signals, was 
extremely difficult for the high density 
puncta and the results were somewhat 
variable. Post hoc manual analysis verified 
that BOPSS was overall remarkably accurate 
but not perfect, as it occasionally under-
counted PLA puncta for high density 
signals (Supplementary Figure 2G), but also 
occasionally overcounted signal in nuclear 
areas (Supplementary Figure 2G–I).
Compared with the other two automated 
quantification methods described previ-
ously, BOPSS avoided time-consuming and 
potentially biased parameter optimization, 
but nonetheless resulted in comparable 
quantification results for the dual PLA and 
negative controls as ICY_D (Figure 4Q). At the 
same time, BOPSS significantly improved 
detection of dense single PLA signal, 
leading to comparable results for single 
PLA as ICY_S (with optimized parameters for 
single PLA) (Figure 4P: BOPSS). Therefore, 
BOPSS achieved a favorable S/N for dual 
PLA similar to that of ICY_D (Figure 4Q) 
by reducing nonspecific detection without 
underestimating real PLA puncta, and simul-
taneously overcame the underestimation 
issue for single PLA. In addition, BOPSS led 
to comparable results as manual counting of 
PLA puncta (Supplementary Figure 2), and 
was much more consistent than manual 
quantification, which is an advantage for 
processing a large dataset in an unbiased 
manner. Thus, overall, BOPSS seems to be 
a straightforward approach for achieving 
completely automated, efficient and specific 
detection of PLA signals and worked equally 
well for both single PLA (puncta of high 
density) and dual (or negative) PLA signal 
(puncta of low density).
PLA has been previously applied to 
postmortem human brains in a very limited 
number of studies [34,35] and optimi-
zation of unbiased quantification methods 
has not been achieved. Combining whole 
slide scanning microscopy, the systematic 
random sampling method, and automated 
quantification with BOPSS, we developed 
here a systematic automated approach 
for quantitative study of PLA-BF, which 
enhanced our data analysis capacity to the 
level required for processing image data 
from the human brain.
Quantifying the expression of D2R, 
A2AR & D2R-A2AR in the human brain
Because the ventral striatum tissue blocks 
contained only partial Ptm and Cdt of 
varied sizes, we focused their quantifi-
cation on the NAcc. The quantification 
results from the three human subjects 
(Supplementary Table 1) showed varied 
counts of D2R, A2AR and D2R-A2AR 
complex in the NAcc (Supplementary 
Figure 3A–C). The averaged relative 
fractions of D2R-A2AR complex were 
12.3 ± 1.8% relative to total A2AR and 
13.4 ± 5.3% relative to total D2R. In this 
small preliminary proof-of-concept 
analysis, we cannot address whether the 
differences in the absolute levels of 
complex and their levels relative to the two 
single receptors represent true individual 
variation or differences in the exact regions 
quantified (Supplementary Figure 3E & F). 
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Figure 4. Comparison of automated quantification methods. Three counting images of the single (A), dual (B) and negative PLA (C) from subject 
PI12277 were used to test puncta detection and quantification approaches with selected parameters: Particle Analysis (Image J) with auto threshold 
(Image J_Auto, D–F), Spot Detector (ICY) with parameters favoring detection of either dual and negative (ICY_D, G–I) or single (ICY_S, J–L) PLA signals, 
and BOPSS (BOPSS, M–O). Image J and ICY quantified the puncta in the transformed and contrast enhanced images (D–L) as described in the Supple-
mentary data. The counted puncta were marked in red dots (D–F & M–O) or labeled in red numbers (G–L) in the analyzed images. Single PLA puncta 
density results were analyzed with repeated one-way ANOVA; there was a significant effect of quantification method (p = 0.014) (P). Dual PLA and its 
negative control were analyzed by repeated two-way ANOVA, as they shared the same PLA conditions except for the omission of one of the two primary 
antibodies; the interaction between quantification method and PLA signal was not significant (accounts for 3.73% for the total variance, p = 0.21); 
both the quantification method (accounts for 56.9% of the total variance, p = 0.005) and the PLA condition (accounts for 26.22% of the total variance, 
p = 0.009) had significant effects on the variance (Q). Bonferroni’s multiple comparisons were performed for both sets of analyses: to compare BOPSS 
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Nonetheless, the results show that our 
method can allow relative quantification 
for both numbers of antigens as well as the 
proximity between the two antigens.
The existence of heteromers composed 
of A2AR and D2R has been supported 
by multiple studies using different 
approaches, including co-immunoprecip-
itation in vitro, fluorescence resonance 
energy transfer and bioluminescence 
resonance energy transfer in living cells, 
and PLA-FL in rodent striatum, making 
it the most characterized class A GPCR 
heteromer [15–18]. To our knowledge, 
our study is the first to detect D2R-A2AR 
complexes in situ in postmortem human 
brains, suggesting that the physical 
proximity between D2R and A2AR is 
conserved from rodent to human. Whether 
this signal represents true heteromer-
ization of two functional receptors that 
communicate directly or close proximity 
of receptors in microdomains or a larger 
complex remains to be determined. We 
have explored systematic sampling and 
automated quantification methods to 
assess the expression of D2R, A2AR and 
D2R-A2AR among individuals. Although 
the number of samples here was very 
small, the results demonstrate that single 
and dual PLA assays can be carried out 
in paraffin sections of human autopsy 
brains, that the signal can be measured 
by computerized image analysis and that 
the results can be used reliably to explore 
differences in protein expression in a way 
that is vastly more quantitative than tradi-
tional immunostaining. Our study consti-
tutes a proof-of-concept for the feasibility 
of combining PLA and stereology for the 
relative quantitation of GPCRs and their 
complexes in postmortem human brains.
FUTURE PERSPECTIVE
We optimized PLA for use with human brain 
tissue and demonstrated in striatum the 
existence of GPCR complexes composed 
of dopamine receptor D2R and adenosine 
receptor A2AR (D2R-A2AR) that are 
potential therapeutic targets for various 
neurological and psychiatric diseases. Our 
work highlights the utility of PLA in human 
brain sections for semi-quantitative 
analysis of GPCRs and their complexes in 
pathophysiological conditions.
SUPPLEMENTARY DATA
To view the supplementary data that 
accompany this paper please visit the 
journal website at: www.future-science.
com/doi/suppl/10.2144/btn-2019-0083
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